NYSE · X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS · LARGE CAP
Koninklijke Philips NV PHG
11 fiscal years on record · EUR · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
€17.8B
▼ 1.0% vs FY2024
EPS · FY25
€0.93
Dividend / sh · FY25
€0.85
Payout · FY25
—
ROE · FY25
7.8%
Net margin · FY25
5.0%
Dividend coverage
1.1×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
EUR 17.8B
Revenue, FY2025 · full 11-year series below
Revenue
Net income
5 cents of every revenue dollar became profit this year.
Per share
EUR 0.93
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 1.1 times — the rest stayed in the company.
Profitability
7.8%
Return on equity, FY2025
ROE
Operating margin8.0%
Net margin5.0%
Return on assets3.2%
Each EUR of equity produced 8 cents of profit this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksEUR -13.0M
Share of profit0.0%
Consecutive raises—
Growth
+0.6% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+0.0%
+0.6%
+0.6%
Net income
−5.5%
+3.7%
EPS, diluted
−6.3%
+3.2%
Dividend / share
+0.0%
+0.0%
+0.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
EUR 26.9B
total assets, end of FY2025
Total assetsEUR 26.9B
EquityEUR 11.0B
CashEUR 2.8B
Gross debtEUR 8.1B
Net debtEUR 5.3B
Current ratio1.32×
Net debt stands at 48% of equity.
History
11 fiscal years
Every figure from documents filed with the SEC · EUR
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue €B
17.8
18.0
18.2
17.8
17.2
17.3
17.1
18.1
17.8
17.4
16.8
Operating income €B
1.4
0.5
−0.1
−1.5
0.6
1.3
1.4
1.7
1.5
1.5
0.7
EBITDA €B
2.5
1.9
1.1
0.1
1.9
2.7
2.7
2.8
2.5
2.4
1.6
Income tax €B
0.3
1.0
−0.1
−0.1
−0.1
0.2
0.3
0.2
0.3
0.2
0.2
Net income €B
0.9
−0.7
−0.5
−1.6
3.3
1.2
1.2
1.1
1.7
1.4
0.6
EPS, diluted €
0.93
−0.75
−0.49
−1.69
3.50
1.29
1.25
1.14
1.75
1.56
0.68
Dividend / sh €
0.85
0.85
0.85
0.85
0.85
0.85
0.85
0.80
0.80
0.80
0.80
Payout %
·
·
−161
−46
23
64
39
37
45
51
48
ROE %
7.8
−5.8
−3.7
−11.6
25.2
9.7
9.5
9.1
13.5
12.0
5.4
Shares out B
·
·
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
42 of 42
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed